| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | P Control 1A-01_7_1_3213 | Treatment:A549-P | AU |
| Reversed phase POSITIVE ION MODE | P Control 1A-02_7_1_3214 | Treatment:A549-P | AU |
| Reversed phase POSITIVE ION MODE | P Control 2A-01_8_1_3215 | Treatment:A549-P | AU |
| Reversed phase POSITIVE ION MODE | P Control 2A-02_8_1_3216 | Treatment:A549-P | AU |
| Reversed phase POSITIVE ION MODE | P Control 3A-01_9_1_3217 | Treatment:A549-P | AU |
| Reversed phase POSITIVE ION MODE | P Control 3A-02_9_1_3222 | Treatment:A549-P | AU |
| Reversed phase POSITIVE ION MODE | R Control 1A-01_13_1_3229 | Treatment:A549-P | AU |
| Reversed phase POSITIVE ION MODE | R Control 1A-02_13_1_3230 | Treatment:A549-R | AU |
| Reversed phase POSITIVE ION MODE | R Control 2A-01_14_1_3231 | Treatment:A549-R | AU |
| Reversed phase POSITIVE ION MODE | R Control 2A-02_14_1_3232 | Treatment:A549-R | AU |
| Reversed phase POSITIVE ION MODE | R Control 3A-01_15_1_3233 | Treatment:A549-R | AU |
| Reversed phase POSITIVE ION MODE | R Control 3A-02_15_1_3234 | Treatment:A549-R | AU |
Return to study ST002703 main page
Download data matrix(Multi-Omics Analysis Revealed a Significant Molecular Changes in Doxorubicin-Resistant Lung Cancer Cells. Reversed phase POSITIVE ION MODE)
- Metabolomics Workbench
|